BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36401434)

  • 1. Association of hormone receptor status with cardiovascular disease mortality in 399,209 patients with stage I to III breast cancer: A population-based study.
    Lai Z; Wang L; Liao X; Chen Y; Liu C; Wang C; He J
    Medicine (Baltimore); 2022 Nov; 101(46):e31911. PubMed ID: 36401434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events.
    Hershman DL; Accordino MK; Shen S; Buono D; Crew KD; Kalinsky K; Trivedi MS; Hur C; Hu J; Unger JM; Wright JD
    Cancer; 2020 Apr; 126(7):1541-1549. PubMed ID: 31913500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
    Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
    Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.
    He J; Wang S; Liu H; Duan C; Zhang H; Wen F; Zhang C
    Transl Cancer Res; 2023 Dec; 12(12):3591-3603. PubMed ID: 38192997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality from cardiovascular disease in women with breast cancer - a nationwide registry study.
    Kolodziejczyk C; Jakobsen M; Sall Jensen M; Poulsen PB; Khan H; Kümler T; Andersson M
    Acta Oncol; 2021 Oct; 60(10):1257-1263. PubMed ID: 34339355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain.
    Clèries R; Ameijide A; Buxó M; Vilardell M; Martínez JM; Font R; Marcos-Gragera R; Puigdemont M; Viñas G; Carulla M; Espinàs JA; Galceran J; Izquierdo Á; Borràs JM
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case-control study.
    Möhl A; Behrens S; Flaßkamp F; Obi N; Kreienbrinck A; Holleczek B; Gali K; Chang-Claude J; Becher H
    Breast Cancer Res; 2023 Jul; 25(1):89. PubMed ID: 37501086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer.
    Calip GS; Nabulsi NA; Hubbard C; Asfaw AA; Lee I; Zhou J; Cueto J; Mitra D; Ko NY; Hoskins KF; Law EH
    Cancer Causes Control; 2022 May; 33(5):793-799. PubMed ID: 35226243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.
    Greenlee H; Iribarren C; Rana JS; Cheng R; Nguyen-Huynh M; Rillamas-Sun E; Shi Z; Laurent CA; Lee VS; Roh JM; Santiago-Torres M; Shen H; Hershman DL; Kushi LH; Neugebauer R; Kwan ML
    J Clin Oncol; 2022 May; 40(15):1647-1658. PubMed ID: 35385342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
    Wang X; Song J; Long J; Zeng Z; Liu A
    Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease After Aromatase Inhibitor Use.
    Haque R; Shi J; Schottinger JE; Chung J; Avila C; Amundsen B; Xu X; Barac A; Chlebowski RT
    JAMA Oncol; 2016 Dec; 2(12):1590-1597. PubMed ID: 27100398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
    Bardia A; Arieas ET; Zhang Z; Defilippis A; Tarpinian K; Jeter S; Nguyen A; Henry NL; Flockhart DA; Hayes DF; Hayden J; Storniolo AM; Armstrong DK; Davidson NE; Fetting J; Ouyang P; Wolff AC; Blumenthal RS; Ashen MD; Stearns V
    Breast Cancer Res Treat; 2012 Feb; 131(3):907-14. PubMed ID: 22042368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
    Ramin C; Schaeffer ML; Zheng Z; Connor AE; Hoffman-Bolton J; Lau B; Visvanathan K
    J Natl Cancer Inst; 2021 Feb; 113(2):137-145. PubMed ID: 32634223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
    Li Z; Wang K; Shi Y; Zhang X; Wen J
    Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.
    Guan T; Su M; Luo Z; Peng W; Zhou R; Lu Z; Feng M; Li W; Teng Y; Jiang Y; Ou C; Chen M
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort.
    Shen K; Yao L; Zhu J; Gu X; Wang J; Qian W; Zheng Z; Fu D; Wu S
    BMC Cancer; 2022 Aug; 22(1):863. PubMed ID: 35941565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
    Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era.
    Murphy AC; Koshy AN; Farouque O; Yeo B; Roccisano L; Octavia Y; Yudi MB
    Heart Lung Circ; 2024 May; 33(5):648-656. PubMed ID: 37574416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
    Azim HA; Kroman N; Paesmans M; Gelber S; Rotmensz N; Ameye L; De Mattos-Arruda L; Pistilli B; Pinto A; Jensen MB; Cordoba O; de Azambuja E; Goldhirsch A; Piccart MJ; Peccatori FA
    J Clin Oncol; 2013 Jan; 31(1):73-9. PubMed ID: 23169515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.